Publication | Closed Access
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial
57
Citations
24
References
2018
Year
NCT02596334 and EudraCT 2015-002853-36.
| Year | Citations | |
|---|---|---|
Page 1
Page 1